Jillian Fahey
About Jillian Fahey
Jillian Fahey is the Sr. Director of CAR T Market Access Managers at Bristol Myers Squibb, with over 20 years of experience in the healthcare and pharmaceutical industry.
Current Position at Bristol Myers Squibb
Jillian Fahey is the Sr. Director of CAR T Market Access Managers at Bristol Myers Squibb. In this role, she oversees market access strategies for CAR T therapies, ensuring that these innovative treatments are accessible to patients who need them. Her work focuses on navigating the complex landscape of healthcare policy and reimbursement to support the effective delivery of CAR T therapies.
Previous Roles at Bristol Myers Squibb
Jillian Fahey held significant positions at Bristol Myers Squibb before her current role. From 2022 to 2024, she served as the Director of CAR T Franchise Access Marketing & Policy. Prior to that, she was the Director of CAR T Policy & Reimbursement from 2020 to 2022. In these roles, she developed and implemented strategies to address policy and reimbursement challenges for CAR T therapies.
Experience at Celgene
Before joining Bristol Myers Squibb, Jillian Fahey worked at Celgene, starting as a Manager of Patient Support & Reimbursement from 2011 to 2013. She then served as the Associate Director of Channel Marketing from 2013 to 2019 and was promoted to Director of Organized Customer Marketing from 2019 to 2020. Her tenure at Celgene demonstrated her expertise in healthcare marketing and customer relations.
Early Career at Covance Health Economics
Jillian Fahey began her career at Covance Health Economics, where she worked as a Lead Associate/Program Associate from 2002 to 2007. During her time at Covance, she focused on health economics and program management, which laid the foundation for her expertise in the healthcare and pharmaceutical industry.
Educational Background
Jillian Fahey earned her Bachelor of Arts degree in Psychology from Gettysburg College, where she studied from 1998 to 2002. Her educational background in psychology provided her with a strong understanding of behavioral sciences, which has been instrumental in her career in healthcare and pharmaceutical market access.